US › Healthcare

Rxsight Inc (RXST)

US · Healthcare · Medical Devices

$5.32-1.48%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$33.7M

Revenue YoY

+0.3%

Net profit

$-12.1M

EPS

$-0.29

EPS estimate

$-0.37

Net margin

-35.9%

EPS came in at -0.29 against a street estimate of -0.37 — a beat of 21.6%.

Key statistics

Market cap

$247.9M

Forward P/E

116.3

P/B

1.00

Book value

$6.33

EPS (TTM)

$-1.08

52-week high

$13.22

52-week low

$4.48

50-day MA

$6.04

200-day MA

$7.52

Beta

1.16

Analyst view

Analysts rate Rxsight Inc a buy (6 buy, 3 hold, 2 sell out of 11) with an average price target of $7.79.

Shareholding

Insiders

6.48%

Institutions

104.56%

Largest institutional holders

Fund	Stake
BlackRock Inc	7.66%
Millennium Management LLC	7.29%
No Street GP LP	4.94%
Nomura Holdings Inc	4.81%
D. E. Shaw & Co LP	4.77%
Vanguard Capital Management, LLC	4.07%
Two Sigma Investments LLC	3.13%
Bank of America Corp	2.91%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Rxsight Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.